Marimed (MRMD) Total Current Liabilities (2011 - 2026)

Marimed (MRMD) has reported Total Current Liabilities for 16 consecutive years, with $63.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Current Liabilities rose 25.14% year-over-year to $63.8 million in Q2 2026; TTM through Jun 2026 was $63.8 million, a 25.14% increase from a year earlier, with the FY2025 full-year figure at $59.1 million, up 18.12% from the prior year.
• Total Current Liabilities was $63.8 million for Q2 2026 at Marimed, roughly flat from $63.8 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $63.8 million in Q1 2026 and troughed at $24.5 million in Q1 2023.
• A 5-year average of $41.8 million and a median of $38.1 million in 2024 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities surged 134.89% in 2022 and declined 28.3% in 2023, its largest moves.
• Over 5 years, Total Current Liabilities stood at $26.5 million in 2022, then gained by 16.5% to $30.9 million in 2023, then surged by 62.03% to $50.0 million in 2024, then increased by 18.12% to $59.1 million in 2025, then climbed by 7.93% to $63.8 million in 2026.
• The last three Total Current Liabilities figures came in at $63.8 million (Q2 2026), $63.8 million (Q1 2026), and $59.1 million (Q4 2025), per Business Quant data.